Key Findings

The study identifies Eis2 as an aminoglycoside-modifying enzyme that activates florfenicol amine (FF-NH2) by acetylating it to form FF-ac, a more potent translational inhibitor. Mutations in whiB7 and eis2 decrease susceptibility to FF-NH2.